Literature DB >> 1398070

Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a > 20S degradation complex.

S Savant-Bhonsale1, D W Cleveland.   

Abstract

Many short-lived mRNAs, including those encoding lymphokines, cytokines, and proto-oncogenes, contain an AU-rich sequence in their 3'-untranslated regions. These AU domains and, more specifically, AUUUA motifs within them, are widely thought to mediate the extreme instability of the corresponding mRNAs. This is most clearly true for granulocyte monocyte colony stimulating factor (GM-CSF) mRNA whose AUUUA motifs are conserved phylogenetically and whose presence in an otherwise stable beta-globin mRNA results in a 50-fold decrease in accumulated mRNA level. We show that RNA instability conferred by the GM-CSF AU motif requires the mRNA to be actively translated and the AU motif to be within the 3'-untranslated region. By analysis of the sedimentation characteristics, we identify a large (> 20S), divalent cation-independent complex found only on unstable RNAs. Like instability, complex formation (1) is dependent on translation of the RNA, (2) requires intact AUUUA motifs, and (3) is blocked by ribosome translocation across the AU-rich motif. We propose that RNA instability mediated by the AU motif is achieved through translation-dependent assembly of this large mRNA-destabilizing complex.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398070     DOI: 10.1101/gad.6.10.1927

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  82 in total

Review 1.  Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome.

Authors:  J D Keene
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

2.  The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology.

Authors:  C M Misquitta; V R Iyer; E S Werstiuk; A K Grover
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

3.  Regulation of AUF1 expression via conserved alternatively spliced elements in the 3' untranslated region.

Authors:  G M Wilson; Y Sun; J Sellers; H Lu; N Penkar; G Dillard; G Brewer
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

Review 4.  Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping.

Authors:  Sunghoon Kim; Sungyong You; Daehee Hwang
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 5.  The role of AUF1 in regulated mRNA decay.

Authors:  Frances M Gratacós; Gary Brewer
Journal:  Wiley Interdiscip Rev RNA       Date:  2010 Nov-Dec       Impact factor: 9.957

6.  Selective degradation of early-response-gene mRNAs: functional analyses of sequence features of the AU-rich elements.

Authors:  C Y Chen; A B Shyu
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

7.  Rapid mRNA degradation mediated by the c-fos 3' AU-rich element and that mediated by the granulocyte-macrophage colony-stimulating factor 3' AU-rich element occur through similar polysome-associated mechanisms.

Authors:  E Winstall; M Gamache; V Raymond
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

8.  Phenotypic and molecular characterization of SerD, a dominant allele of the Drosophila gene Serrate.

Authors:  U Thomas; F Jönsson; S A Speicher; E Knust
Journal:  Genetics       Date:  1995-01       Impact factor: 4.562

9.  Binding of a 50-kD Protein to a U-Rich Sequence in an mRNA Encoding a Proline-Rich Protein That Is Destabilized by Fungal Elicitor.

Authors:  S. Zhang; M. C. Mehdy
Journal:  Plant Cell       Date:  1994-01       Impact factor: 11.277

10.  Identification and characterization of mutations in the UPF1 gene that affect nonsense suppression and the formation of the Upf protein complex but not mRNA turnover.

Authors:  Y Weng; K Czaplinski; S W Peltz
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.